When Oxygen Saturation Is Critically Low and Red Blood Cell Count Is Too High: A Deep Dive Into the Complex Interplay of Hematological and Metabolic Disorders

By

When a patient presents with critically low oxygen saturation (SpO₂), fainting episodes, and an abnormally high number of red blood cells (erythrocytosis), physicians face a challenging diagnostic puzzle. In such cases, symptoms may not align with typical respiratory pathologies, and initial assumptions about lung dysfunction may be misleading. Instead, the root cause may lie within the blood itself or in deeper systemic conditions, including metabolic or genetic disorders such as acute intermittent porphyria (AIP) or iron storage diseases like hemochromatosis.

This article explores the possible underlying causes, implications, and treatment strategies associated with these intertwined medical findings.

Part I: The Immediate Clinical Picture

Symptoms and Concerns

  • Critically low oxygen saturation despite normal lung function

  • Elevated red blood cell count (polycythemia or erythrocytosis)

  • Episodes of fainting (syncope)

  • Aggressiveness, irritability

  • Liver and kidney dysfunction

  • Signs of systemic toxicity or overload

These symptoms suggest a deeper pathological process beyond typical respiratory or cardiovascular conditions.

Part II: Excluding the Obvious – Pulmonary and Cardiovascular Factors

The lungs are often the first suspect in cases of low SpO₂. However, if pulmonary function tests and imaging show normal gas exchange, ventilation, and perfusion, the focus shifts elsewhere. Similarly, if cardiac causes (e.g., shunts or congestive heart failure) are ruled out, then the blood composition itself must be scrutinized.

Part III: Too Many Red Blood Cells – A Clue, Not a Solution

While red blood cells are essential for oxygen transport, an excess of them does not improve oxygenation. On the contrary, they may increase blood viscosity, impair microcirculation, and paradoxically worsen oxygen delivery.

Potential Causes of Erythrocytosis

  1. Primary polycythemia (Polycythemia vera) – A myeloproliferative disorder.

  2. Secondary erythrocytosis – Due to chronic hypoxia, tumors producing erythropoietin, or high-altitude adaptation.

  3. Relative erythrocytosis – Due to plasma volume loss (dehydration).

In rare cases, metabolic diseases can trigger erythropoiesis as a compensatory or dysfunctional mechanism.

Part IV: The Hidden Culprit – Acute Intermittent Porphyria (AIP)

One often overlooked genetic condition that can present with confusing systemic symptoms is acute intermittent porphyria.

What Is AIP?

AIP is a rare hereditary disorder affecting the synthesis of heme, a crucial component of hemoglobin. It results from a mutation in the gene encoding porphobilinogen deaminase, an enzyme involved in the heme biosynthetic pathway.

Key Features

  • Intermittent, acute attacks of abdominal pain, vomiting, and constipation

  • Neurological symptoms: confusion, seizures, peripheral neuropathy, and even psychosis or aggression

  • Triggers: drugs, alcohol, hormonal changes, fasting

  • Dark or reddish urine after light exposure due to porphyrin precursors

  • No skin involvement (distinguishing it from other porphyrias)

Why It Matters in This Case

AIP can explain:

  • Fainting (due to autonomic dysfunction)

  • Neuropsychiatric symptoms (aggressiveness, irritability)

  • Unclear blood irregularities

  • Organ damage (liver, kidneys)

However, AIP does not directly cause erythrocytosis—which leads us to consider another layered pathology.

Part V: Iron Overload and Hemochromatosis – The Storage Disease

Type 2 Hemochromatosis (Juvenile Hemochromatosis)

A genetic iron storage disorder, hemochromatosis results in excessive iron absorption from the diet, leading to accumulation in tissues and organs.

Symptoms and Complications

  • Organ damage: liver cirrhosis, kidney dysfunction, diabetes, and heart failure

  • Skin discoloration

  • Loss of libido, erectile dysfunction

  • Joint pain and osteoporosis

  • Aggressiveness, depression, fatigue

  • Neurological issues due to iron deposition in the brain

  • Coagulopathy and seizures due to electrolyte imbalances

Blood Abnormalities

The iron is not excreted naturally, so iron overload leads to excessive red blood cell production, as the bone marrow uses available iron to make hemoglobin, increasing RBCs even when oxygen delivery is impaired.

Part VI: Treatment of Iron Overload – Chelation Therapy

Iron chelation is used when phlebotomy (bloodletting) is not enough or not tolerated due to anemia or other conditions.

Chelation Agents

  • Deferoxamine (DFO) – Administered intravenously or subcutaneously

  • Deferiprone (Ferriprox) – Oral chelator used in thalassemia

  • Deferasirox (Exjade) – Oral, once-daily treatment

These chelators bind to free iron in the bloodstream and tissues, forming complexes that are excreted via urine or bile.

Risks and Side Effects

While effective, chelation is not without risks:

  • Electrolyte disturbances (low calcium, zinc, copper)

  • Renal impairment

  • Hearing and vision changes (especially with DFO)

  • Skeletal abnormalities in children

  • Infection susceptibility, especially with Yersinia species

  • Blood clotting issues due to calcium loss

Part VII: Differential Diagnosis – Avoiding Confusion

AIP vs Autoimmune Pancreatitis (also abbreviated AIP)

The term "AIP" can lead to confusion as it refers to two entirely different conditions:

  1. Acute Intermittent Porphyria – A metabolic genetic disorder with neurological and systemic symptoms.

  2. Autoimmune Pancreatitis – A chronic inflammatory condition of the pancreas that is steroid-responsive and often part of a multisystem autoimmune syndrome.

Part VIII: What's at Stake – Risk of Collapse

The convergence of fainting, neuropsychiatric symptoms, metabolic overload, and organ damage creates a life-threatening scenario.

Next Collapse Could Be Fatal

Without timely diagnosis and intervention, the next fainting episode could result in:

  • Severe hypoxia

  • Cardiac arrhythmias

  • Seizures or coma

  • Multi-organ failure

Conclusion: A Complex Interplay of Hematological and Metabolic Factors

The presented case highlights the critical need for a multidisciplinary approach. It is not simply about oxygen levels or red blood cell counts. Instead, it’s about understanding the biochemical, genetic, and systemic factors that disrupt homeostasis.

Probable Diagnosis Hypothesis

  • Primary Diagnosis: Iron storage disorder (likely juvenile hemochromatosis)

  • Contributing Factor: Possible co-existing acute intermittent porphyria

  • Complications: Liver and kidney damage, electrolyte imbalance, neurotoxicity, potential seizures

  • Recommended Treatment: Chelation therapy, monitoring of electrolytes, regular phlebotomy, genetic testing, neurological and psychiatric support

Final Thought

In medicine, not all symptoms follow textbook definitions. Sometimes, multiple rare conditions intersect, painting a confusing picture. But with careful analysis and attention to the body’s systemic language, the underlying truth can be revealed – and lives can be saved.

© 2000-2025 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a fife year copy right. Library of Congress Card Number: LCN 00-192742

Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more